Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Open Traditional Approach

Related Conditions

Often studied with 18 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT03564483RecruitingPrimary

Gynecologic Extramammary Paget's Disease

NCT06873815Phase 2RecruitingPrimary

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

NCT01526486Not ApplicableCompleted

Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer

Showing all 3 trials

Research Network

Common Treatments

  • Open Traditional Approach1
  • Videoscopic Procedure1
  • Fluorescein Sodium1

Active Sponsors

  • Emory University1
  • Mayo Clinic1
  • Memorial Sloan Kettering Cancer Center1

Top Investigators

Related Conditions

  • Extramammary Pagets Disease Of Anal Canal Diagnosis1
  • Extramammary Pagets Disease Vulva Invasive1
  • Penile Carcinoma1
  • Extramammary Pagets Disease Of Skin1
  • Extramammary Pagets Disease Of Vagina Diagnosis1

Activity Timeline